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ABSTRACT
Objective: Hypertension is a major non-communicable disease prevailing globally. This study was conducted to determine the effectiveness of 
laughter therapy on blood pressure among patients with hypertension at a selected hospital, in Kancheepuram District.
Methods: A quantitative approach of pre-experimental one group pre- and post-test design was chosen for this study. A total of 50 samples were 
included in the study using purposive sampling technique. Pre-test was done using the structured instrument, and laughter therapy was implemented 
following which post-test was done for all the study group participants. Both descriptive and inferential statistics were used for analysis.
Results: The distribution of demographic variables depicted that each 17 (34%) study participants were aged from 39-42 to 43-45 years, respectively. 
On the count of gender, male and female study participants were equal in numbers that is each 25 (50%). The distribution of level of blood pressure in 
pre- and post-test disclosed that all the 50 (100%) study group participants had Stage I systolic and diastolic hypertension in the pre- test whereas in 
post-test 45 (90%), had pre-hypertension systolic and diastolic, only 5 (10%) had Stage I systolic and diastolic hypertension. There was a statistically 
significant difference between pre- and post-test systolic and diastolic blood pressure within study group participants at level p<0.001.
Conclusion: This study findings implied that laughter therapy was effective to sustain the blood pressure within the optimal level among patients 
with hypertension.
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INTRODUCTION
The human race has one really effective weapon, and that is laughter.
- Mark Twain
Hypertension is an important medical and public health issue. It exists 
worldwide at epidemic rates affecting an estimated 1 billion people. 
Worldwide, raised blood pressure is estimated to cause 7.5 million 
deaths, about 12.8% of the total of all deaths WHO [1]. The prevalence 
of hypertension in Indians is 25% in urban and 10% in the rural 
population. According to estimates, there are nearly 31.5 million 
hypertensive in rural and 34 million in urban populations. Projections 
show that by 2030, an additional 27 million people could have 
hypertension. Hypertension is directly responsible for 57% of stroke 
deaths and 24% of coronary artery disease deaths in India according 
to Bhushan et al. [2].
Laughter is a natural part of life and is the best medicine. Laughter is 
a powerful antidote to stress, pain, and conflict. Laughter lightens the 
burden, inspires hopes, connects someone to others, and keeps the 
individual, focused and alert. With so much power to heal and renew, 
the ability to laugh easily and frequently is a tremendous resource 
for surmounting problems, enhancing relationships, and supporting 
both physical and emotional health. Laughter helps to control blood 
pressure by reducing the release of stress-related hormones and bring 
relaxation. As far as lowering the blood pressure, studies showed that 
people who laugh heartily on a regular basis have lower standing blood 
pressure than the average person. Hence, a study was conducted to 
identify the effectiveness of laughter therapy on blood pressure among 
patients with hypertension at a selected hospital in Kancheepuram 
District. The objectives of the study were the identification of the 
effectiveness of laughter therapy on blood pressure among patient 
with hypertension and association of demographic, health and clinical 
variables with the level of blood pressure in the post-test among 
patients with hypertension.
METHODS
A quantitative research approach of pre-experimental one group pre-
and post-test design was used for this study. Ethical Committee approval 
was obtained from the institutional ethical committee. The hypothesis 
H1: ”There is a significant difference in the systolic and diastolic blood 
pressure between pre and post test among patients with hypertension 
who were subjected to laughter therapy.”
A total of 50 study participants were recruited for the study using 
purposive sampling technique. The inclusion criteria were patients of 
both male and female diagnosed to have primary hypertension with 
the blood pressure ranging from 140-180 to 90-110 mm of Hg, aged 
between 35 and 45 years and who were able to talk and understand 
Tamil or English.
Patients with mental illness, either visual or hearing impairment, 
disorientation, unable to follow the instructions, diagnosed to have 
Ischemic heart disease, aneurysm, cerebrovascular accident and 
tuberculosis, and with a history of recent pelvic or abdominal surgery, 
who experience acute orthopedic distress such as rib or shoulder 
fracture, were excluded from the study.
The structured instrument was developed by the investigator included 
Part I-IV.
Part-I was demographic variables which included age, sex, marital 
status, religion, educational status, occupational status, and income.
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Part-II was health variables which encompassed body height, weight, 
BMI, sleeping pattern, dietary pattern, history of smoking, history of 
alcoholism, and history of chewing tobacco.
Part-III was clinical variables that consisted of comorbidity, time 
since diagnosis, use of anti-hypertensive medication, and duration of 
treatment.
Part-IV was assessment and classification of blood pressure as shown 
in Table 1.
Data collection procedure
The data were collected using structured instruments Part I-IV. 
Pre-test was performed for all study participants. During the pre-
test, demographic, health variables were collected by interview 
method, except height and weight by anthropometric measurements 
and clinical variables were obtained from the clinical records. The 
blood pressure was measured using calibrated sphygmomanometer 
and stethoscope. The design was divided into pre-test on day 1 and 
practice of laughter therapy for 2 weeks from day 2 to 15 which was 
taught for the patients with hypertension to maintain the blood 
pressure within normal limit. Post-test was done on day 15 for all 
study participants. Teaching was done by lecture cum demonstration 
method with audio-visual aids which included general information 
about hypertension and demonstration of laughter therapy after pre-
test on day 1. Each bout of laughter should last for 30-40 seconds, 
followed by relaxation. It consists of 10 steps and two deep breaths 
are encouraged after every laughter exercise. This was practiced 
by the study participants along with routine care which was only 
antihypertensive medications.
Total duration: 20 minutes.
Initiation: Bend forward swing your hands in front of your body, inhale 
and exhale fully (2 minutes).
•	 Step	 1:	Deep	 breathing	with	 inhalation	 through	 the	 nose	 and	
prolonged exhalation (3 times). (1 minute 30 seconds)
•	 Step	2:	Hearty	laughter	-	Laughter	by	raising	both	the	arms	in	the	
sky with the head tilted a little backward. Feel as if laughter is 
coming right from your heart while laughing chant “Aaa” (1 minute 
30 seconds)
•	 Step	3:	Hearty	laughter	-	Laughter	by	raising	both	the	arms	in	the	
sky with the head tilted a little backward. Feel as if laughter is 
coming right from your heart while laughing chant “Eee” (1 minute 
30 seconds)
•	 Step	4:	Hearty	laughter	-	Laughter	by	raising	both	the	arms	in	the	
sky with the head tilted a little backward. Feel as if laughter is 
coming right from your heart while laughing chant “Uuu” (1 minute 
30 seconds)
•	 Step	5:	Silent	laughter	(with	mouth	closed)	-	Laughter	with	closed	
mouth and a humming sound, while humming keep on moving 
in the group and shaking hands with different people. (1 minute 
30 seconds)
•	 Step	6:	Greeting	laughter	-	Joining	both	the	hands	and	greeting	in	
Indian style (namaste) or shaking hands in Western style with at 
least 4-5 people in the group. (1 minute 30 seconds)
•	 Step	7:	Appreciation	laughter	-	 Join	your	pointing	finger	with	the	
thumb to make a small circle while making gestures as if you are 
appreciating your group members and laughing simultaneously. 
(1 minute 30 seconds)
•	 Step	8:	Swinging	laughter	-	Stand	in	a	circle	and	move	toward	the	
center by chanting Aee...Eeee...Oooo...Uuuu... (1 minute 30 seconds)
•	 Step	9:	Lion	laughter:	Extend	the	tongue	fully	with	eyes	wide	open	
and hands stretched out like the claws of lion and laugh from tummy. 
(1 minute 30 seconds)
•	 Step	10:	Argument	laughter	-	Laugh	by	pointing	fingers	at	different	
group members as if arguing. (1 minute 30 seconds).
Relaxation: Sitting calmly. (3 minutes).
Statistical analysis
The data were analyzed by the statistical package for social sciences 
version 16. Both descriptive and inferential statistics were used for 
analysis. The paired t-test was computed to test the differences in the 
blood pressure within study group participants between pre- and post-
test. The hypothesis H1: ”There is a significant difference in the systolic 
and diastolic blood pressure between pre and post-test among patients 
with hypertension who were subjected to laughter therapy” was tested 
in this study.
RESULTS
TThe distribution of demographic variables  as per Table 2 revealed 
that each 17 (34%) study participants were aged from 39-42 to 43-45 
years, respectively. On the count of gender, male and female study 
participants were equal in numbers that is each 25 (50%). With regard 
to marital status, most of the 35 (70%) study group participants are 
married 8 (16%) were widow/widower, 5 (10%) were separated, 
and only 2 (4%) were unmarried. The majority of 39 (78%) study 
participant were Hindus, 6 (12%) were Muslims and only 5 (10%) 
were Christians. On the account of educational status 14 (28%), 
Table 1: Classification of blood pressure
Classification of 
blood pressure
Systolic (mm of Hg) Diastolic (mm of Hg)
Normal <120 And <80
Prehypertension 120–139 Or 80–89
Stage 1 hypertension 140–159 Or 90–99
Stage 2 hypertension ≥160 Or	≥100
*National institute of health, seventh report of the national committee (2008), 
AHA.[3] AHA: American Heart Association
Table 2: Distribution of demographic variables among study 
group (n=50)


















Primary school 14 (28)
High school 12 (24)
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Graduate 7 (14)
Post-graduate 5 (10)
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12 (24%), 10 (20%), and 7 (14%) study participants had primary 
school, high school, higher secondary school, and graduate level 
of education, respectively. The distribution of occupational status 
revealed that 17 (34%), 14 (28%), and 12 (24%) study participants 
were formers, private employees, and labors, respectively. Out of 50 
study participants, 21 (42%) had the income of Rs. >7500/- month, 
whereas 17 (34%) and 12 (24%) had Rs. < 5000 and Rs. 5001-7500 per 
month, respectively.
The distribution of health variables as illustrated in Table 3 among study 
group participants disclosed that 8 (16%), 17 (34%), and 25 (50%) study 
participants had the height with the range of 140-150, 151-160, and more 
than 160 cms, respectively. With regard to the body weight 19 (38%), 
study group participants were between 55.1 and 65 kg, whereas 15(30%) 
were between 45.1 and 55 kg. However, 11 (22%) study participants had 
the body weight of more than 65 kg and only 5(10%) had >45 kg. On 
calculation of body mass index, 26(52%), 18(36%), 4(8%), and 2 (4%) 
study group participants had between 25-29.9, 18.5-24.9, 30-34.9, and 
35-39.9, respectively. On the account of sleeping pattern (hours/day) 
22 (44%), 21 (42%), and 7 (14%) had 6-8 more than 8 and <6 hours/day. 
Most of the 36 (72%) study participants were non-vegetarians and only 
14 (28%) were vegetarians. With respect to the history of smoking 
17 (34%) were used to smoke “always” and 8(16%) used it “occasionally.” 
Most of the 25 (50%) study group participants “never” used to smoke 
and drink alcohol. The distribution of history of alcoholism unveiled that 
13 (26%) and 12 (24%) study participants used the alcohol “always” and 
“occasional,” respectively. Out of 50 (100%) study group participants, 
29 (58%) did not have the history of chewing tobacco whereas 15 (30%) 
and 6 (12%) used it “occasionally” and “always.”
The distribution of clinical variables as shown in Table 4 disclosed that 
31 (62%) study group participants had comorbid illness, among which 
12 (24%), 6 (12%), 6 (12%), 4 (8%), and 3 (6%) had diabetes mellitus, 
hypothyroidism bronchial asthma, diabetes mellitus with bronchial 
asthma, and diabetes mellitus with hypothyroidism, respectively.
Out of 50 (100%) study group participants 24 (48%), 14 (28%), and 
12 (24%) were diagnosed to have hypertension since 1-5 years, <1 year 
and more than 5 years, respectively. All the 50 (100%) study group 
participants were on treatment, among these 24 (48%), 14 (28%), and 
12 (24%) were on treatment for 1-5 years, for 1 year and more than 
5 years, respectively.
The distribution of level of blood pressure  in pre- and post-test as 
mentioned in Table 5 disclosed that all the 50 (100%) study group 
participants had Stage I systolic and diastolic hypertension in the 
pre-test whereas in post test 45 (90%) had pre-hypertension systolic and 
diastolic ,only 5 (10%) had Stage I  systolic and diastolic hypertension.
The comparison of pre- and post-test blood pressure within study group 
as shown in Table 6 and Fig. 1 disclosed that there was a statistically 
significant difference between pre- and post-test systolic and diastolic 
blood pressure within study group participants at level p<0.001.
DISCUSSION
The distribution of level of blood pressure in pre- and post-test unveiled 
that all the 50 (100%) study group participants had Stage-I systolic 
Fig. 1: Comparison of pre- and post-test mean blood pressure 
among study group
Table 3: Distribution of health variables among study 
group (n=50)



































Table 4: Distribution of clinical variables among study 
group (n=50)





No comorbid illness 19 (38)
Diabetes mellitus 12 (24)
Hypothyroidism 6 (12)
Bronchial asthma 6 (12)
Diabetes mellitus with bronchial asthma 4 (8)
Diabetes mellitus with hypothyroidism 3 (6)
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and diastolic hypertension, whereas in the post-test 45 (90%) had 
pre-hypertension systolic and diastolic blood pressure. The paired “t” value 
on a comparison of pre and post-test systolic and diastolic blood pressure 
within study group participants were 17.785 and 17.956 respectively 
which revealed the statistically significant difference at level p<0.001.
These study findings are further supported by another study conducted 
by Angeline and Madhavi [4]. The findings disclosed that the practice 
of laughter therapy for 20-30 minutes (one session per day for 5 days) 
by the patients with hypertension reduced the blood pressure to 
125.15/82.25 mm of Hg, which was statistically significant at p<0.05.
These findings are substantiated by the study conducted by Nagoor and 
Dudekula which unveiled that laughter therapy reduced the systolic 
and diastolic blood pressure and there was a statistically significant 
difference between pre- and post-test at p<0.01 [5]. Another study 
carried	out	by	Jalali	et al. to evaluate the effect of laughter therapy on 
blood pressure among patients with hypertension disclosed that there 
was a statistically significant difference between pre- and post-test on 
blood pressure at p<0.05 [6].
All the above evidences proved that laughter therapy is very effective to 
reduce the blood pressure among patients with hypertension.
Non-pharmacological interventions are proved to be effective to 
maintain the blood pressure within normal limit. A study conducted by 
Sujatha	and	Judie	on	the	effectiveness	of	a	12-week	yoga	program	on	
physiopsychological parameters in patients with hypertension revealed 
that there was a significant reduction of blood pressure (p<0.001). 
This signifies the importance of nonpharmacological therapy to 
maintain the blood pressure within normal limit among patients with 
hypertension [7].
Hence H1 “There is a significant difference in the systolic and diastolic 
blood pressure between pre and post test among patients with 
hypertension who were subjected to laughter therpy“ is accepted.
Hypertension and its treatment increase the economic burden (EB) 
and psychological burden which is evident from the study conducted 
by Ramanna et al. The result revealed that the cost of therapy was 
higher for DM+HTN and DM. The percentage of expenditure was higher 
in low-income group and burden of therapy was directly proportional 
to the number of tablets, poor educational and occupational status; 
and inversely proportional to income [8]. These study findings are 
substantiated by another study done by Nachiya et al. revealed 
that direct and indirect nonmedical costs have incurred high when 
compared with the other costs of prescription involved in the treatment 
of hypertension in rural inpatients at tertiary care teaching hospital. 
The annual average total direct (medical and non-medical) costs per 
patient	and	total	cost	of	illness	were	₹1,417,253.8	and	₹27,993,470.0,	
respectively [9].
It is evident from the above findings that prevention and control 
of hypertension is vital to reduce the cost of treatment and EB. This 
is further supported by the study conducted by Suhadi et al. which 
disclosed that the total therapy expenditure was likely to be influenced 
by hypertension comorbidity. The findings denoted that preventing 
hypertension comorbidity has the benefit to reduce total therapy 
expenditure. Thus, it proved that prevention is better than cure which 
has to be emphasized among people who is at risk to hypertension. 
Laughter therapy is very simple to practice by all age group of 
people which requires only attitude to adhere to it that will prevent 
hypertension [10].
CONCLUSION
Laughter therapy is an effective intervention to reduce the blood 
pressure among patients with hypertension. Since hypertension is 
a chronic disease, the regular practice of laughter therapy helps the 
patients with hypertension to sustain the blood pressure within normal 
limit throughout their survivorship. This will reduce the complications 
related to hypertension and cost of health care.
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